Beedimani, R.S. and Kalmath, B. 2017. Canagliflozin: a novel ‘glucuretic’ approach for the treatment of type 2 diabetes mellitus. International Journal of Basic & Clinical Pharmacology. 3, 3 (Jan. 2017), 578–580.